GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies: 64,583 Shares Bought Back on Oct 28

BUYBACK ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 28 Oct 2026, 06:12 PM IST  ·  BSE ID: 72a5ea3c-b89c-4894-a5ee-f07e303d5272
View Original BSE Filing (PDF)
💡
In Simple Terms
The company repurchased 64,583 of its own shares on October 28, 2026, at an average price of ₹262.4914 per share.
🤖 AI Summary
  • Advanced Enzyme bought back 64,583 equity shares on October 28, 2026.
  • The average acquisition price for these shares was ₹262.4914.
  • This buyback is conducted through the stock exchange mechanism.
  • The cumulative shares bought back now stand at 23,56,451.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Equity Shares bought back on October 28, 2026
64,583
Average Price of acquisition
₹262.4914
Cumulative Equity Shares bought back as on October 28, 2026
23,56,451
🏢 How This Affects the Company
💰
Financial Impact
The buyback reduces the total number of outstanding shares, potentially impacting earnings per share calculations and improving return ratios.
⚠️
Risk Impact
Increased cash outflow for share repurchases could impact liquidity if not managed alongside operational cash flows.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders.
👤
Who Is Affected
All shareholders benefit from a potential reduction in the number of outstanding shares and increased EPS.
🔍
Management Signal
The ongoing share buyback program indicates management's belief that the company's shares are undervalued.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Daily buyback reports for continued share repurchases.
Next quarterly financial results announcement.
Company disclosures on total buyback completion status.
LOW RISK Routine regulatory filing detailing an executed share buyback transaction.
💡 Investor Takeaway
Advanced Enzyme Technologies bought back 64,583 equity shares on October 28, 2026, at an average price of ₹262.4914. Cumulative buybacks reached 23,56,451 shares.
⚖️ Strengths & Concerns

✅ Positives

  • Active buyback program in progress, signaling management confidence in intrinsic value.
  • Consistent daily buyback activity demonstrates execution of capital allocation strategy.
📅 Company Track Record
Previous buyback activity reported includes 29,115 shares on Oct 27 at ₹256.4868, 61,900 shares on Oct 26 at ₹251.2710, and 57,000 shares on Oct 21 at ₹262.7600.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many shares did Advanced Enzyme Technologies buy back on October 28, 2026?
Advanced Enzyme Technologies bought back 64,583 equity shares on October 28, 2026.
What was the average price of shares bought back by Advanced Enzyme on October 28, 2026?
The average acquisition price of the shares bought back on October 28, 2026, was ₹262.4914.
What is the total number of shares Advanced Enzyme has bought back to date?
As of October 28, 2026, the total number of equity shares bought back by Advanced Enzyme is 23,56,451.
Under which SEBI regulations is Advanced Enzyme conducting its buyback?
Advanced Enzyme is conducting its buyback pursuant to the SEBI (Buy-Back of Securities) Regulations, 2018, as amended.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.